Centene Corporation, a healthcare enterprise in Missouri, serves under-insured families and commercial organizations in the U.S. Despite lagging behind the market last year, CNC stock has slightly outperformed in 2026. The company experienced a 10.7% drop on Jan. 27 after a lower-than-expected payment rate increase for 2027 Medicare Advantage plans. Analysts predict a 72% decline in adjusted EPS for the fiscal year ending in December 2025. Wall Street sentiment towards CNC is improving, with four “Strong Buy” ratings. Analysts have raised price targets for the stock, reflecting a more positive outlook for Centene.

Read more at Yahoo Finance: Are Wall Street Analysts Bullish on Centene Stock?